Characteristic brain hypoperfusion by 99mTc-ECD single photon emission computed tomography (SPECT) in patients with the first-episode schizophrenia

European Psychiatry

Volumn 25, Issue 6, 2010, Pages 361-365

  Wake, R ^a   Miyaoka, T ^a   Kawakami, K ^a   Tsuchie, K ^a   Inagaki, T ^a   Horiguchi, J ^a   Yamamoto, Y ^b   Hayashi, T ^b   Kitagaki, H ^b  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

Neuroimaging; Schizophrenia; SPECT

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

ADULT; AGE DISTRIBUTION; ANALYTIC METHOD; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST EPISODE SCHIZOPHRENIA; FRONTAL LOBE; HUMAN; MALE; MENTAL PATIENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

ADULT; BRAIN; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; CYSTEINE; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SCHIZOPHRENIA; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77956885208     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2009.12.005     Document Type: Article

References (37)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, 273-315. American Psychiatric Press, Washington, DC. 4th ed.
2. Andreasen N.C. Neural mechanisms of negative symptoms. Br J Psychiatry 1989, 155(Suppl. 7):93-98.
3. Andreasen N.C., Razai K., Alliger R., Swayze V.W., Flaum M., Kirchner P., et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992, 49:943-958.
4. Andreasen N.C., Flashman L., Flaum M., Arndt S., Swayze V., O'Leary D.S., et al. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 1994, 272:1763-1769.
5. Benes F.M., McSparren J., Bird E.D., San Giovanni J.P., Vicent S.L. Deficits in small interneurons in prefrontal and cingulated cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 1991, 48:996-1001.
6. Catafau A.M., Parellada E., Lomena F.J., Bernardo M., Pavia J., Ros D., et al. Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease. J Nucl Med 1994, 35:935-941.
7. Ebert D., Feistel H., Kaschka W. Left temporal hypoperfusion in catatonic syndromes: a SPECT study. Psychiatry Res Neuroimaging 1992, 45:239-241.
8. Flor-Henry P. Lateralized temporal-limbic dysfunction and psychopathology. Ann N Y Acad Sci 1976, 280:777-797.
9. Gonul A.S., Kula M., Esel E., Tutus A., Sofuoglu S. A Tc-99m HMPAO SPECT study of regional cerebral blood flow in drug-free schizophrenic patients with deficit and non-deficit syndrome. Psychiatry Res Neuroimaging 2003, 123:199-205.
10. Guedj E., Taieb D., Cammilleri S., Lussato D., Laforte C., Nioyet J., et al. 99mTc-ECD brain perfusion SPECT in hyperalgestic fibromyalgia. Eur J Nucl Med Mol Imaging 2007, 34:130-134.
11. Heckers S., Goff D., Schacter D.L., Savage C.R., Fischman A.J., Alpert N.M., et al. Functional imaging memory retrieval in deficit vs. nondeficit schizophrenia. Arch Gen Psychiatry 1999, 56:1117-1123.
12. Honey G.D., Sharma T., Suckling J., Giampietro V., Soni W., Williams S.C., et al. The functional neuroanatomy of schizophrenic subsyndromes. Psychol Med 2003, 33:1007-1018.
13. Hyun Y., Lee J.S., Rha J.H., Lee I.K., Ha C.K., Lee D.S. Different uptake of 99mTc ECD and 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping. Eur J Nucl Med 2001, 28:191-197.
14. Ingvar D.H., Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 1974, 50:425-462.
15. Ingvar D.H., Franzen G. Distribution of cerebral activity in chronic schizophrenia. Lancet 1974, 2:1484-1486.
16. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
17. Kohno T., Shiga T., Kageyama H., Kaji T., Katoh C., Tamaki N. Left temporal perfusion is positively correlated with suspiciousness score in schizophrenia. Psychiatry Res Neuroimaging 2006, 147:163-171.
18. Kraepelin E. Dementia Praecox and Paraphrenia 1971, R.E. Krieger Publishing Co., Huntington, NY.
19. Miller D.D., Andreasen N.C., O'Leary D.S., Watkins G.L., Ponto L.L.B., Hichwa R.D. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol Psychiatry 2001, 49:704-715.
20. Min S.K., An S.K., Jon D.I., Lee J.D. Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study. Psychiatry Res Neuroimaging 1999, 90:159-168.
21. Minoshima S., Koeppe R.A., Frey K.A., Kuhl D.E. Anatomical standardization: Linear scaling and non linear warping pgi functional brain images. J Nucl Med 1994, 35:1528-1537.
22. Minoshima S., Frey K.A., Koeppe R.A., Foster N.L., Kuhl D.E. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorin-18-FDG PET. J Nucl Med 1995, 36:1238-1248.
23. Minoshima S., Giordni B., Berent S., Foster N.L., Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997, 42:85-94.
24. Mizumura S., Kumita S. Stereotactic statistical imaging analysis of the brain using the easy Z-score imaging system for sharing a normal database. Radiat Med 2006, 24:545-552.
25. Molina V., Gispert J.D., Reig S., Pascau J., Martinez R., Sanz J., et al. Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia. Int Clin Psychopharmacol 2005, 20:13-18.
26. Molina V., Gispert J.D., Reig S., Sanz J., Pascau J., Santos A., et al. Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement. Psychopharmacology 2005, 178:17-26.
27. Musalek M., Podreka I., Walter H. Regional brain function in hallucinations: a study of regional cerebral blood flow with 99mTc-HMPAO-SPECT in patients with auditory hallucinations, tactile hallucinations and normal controls. Compr Psychiatry 1989, 30:99-108.
28. Nester P.G., Shenton M.E., McCarly R.W. Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia. Am J Psychiatry 1993, 150:1849-1855.
29. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
30. Overall J.E., Gorham D.E. The brief psychiatric rating scale. Psychol Rep 1962, 10:799-812.
31. Parellada E., Catafau A.M., Bernardo M., Lomena F., Catarineu S., Gonzalez-Monclus E. The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients. Biol Psychiatry 1998, 44:787-790.
32. Puri B.K., Lekh S.K., Nijran K.S., Bagary M.S., Richardson A.J. SPECT neuroimaging in schizophrenia with religious delusions. Int J Psychophysiol 2001, 40:143-148.
33. Rajkowska G., Selemon L.D., Goldman- Rakic P.S. Neuronal and glial somal size in prefrontal cortex. A post mortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998, 55:215-224.
34. Shenton M.E., Dickey C.C., Frumin M., Mc Carley R.W. A review of MRI findings in schizophrenia. Schizophr Res 2001, 49:1-52.
35. Suzuki M., Nohara S., Hagino H., Kurokawa K., Yotsutsuji T., Kawasaki Y., et al. Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr Res 2002, 55:41-54.
36. Tamminga C.A., Thaker O.K., Buchanan R., Kirkpatrick B., Alphs L.D., Chase T.N., et al. Limbic system abnormalities identified in schizophrenis using positron emission tomography with fluorodeoxyglucose and neocortical alteration with deficit syndrome. Arch Gen Psychiatry 1992, 49:522-530.
37. Vita A., Bressi S., Perani D. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. Am J Psychiatry 1995, 152:876-882.